You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
28 July 2021
Sanofi is handing over distribution and marketing of around 50 consumer healthcare brands in 20 European countries to Germany’s Stada.
15 July 2021
Stada has launched Austria’s first non-prescription migraine treatment containing a triptan. The Austrian initiative was “tailored to the local market conditions and opportunities”, Stada told OTCToolbox, adding that the company “continues to explore opportunities for prescription-to-OTC switches wh...
13 July 2021
Stada has inlicensed exclusive rights to Enzymatica’s ViruProtect in Vietnam and plans to launch the common cold spray in the country in 2022.
29 June 2021
Stada is strengthening its European consumer healthcare presence by acquiring 16 local and regional brands – including Silomat, Mitosyl and Frubiase – from Sanofi Consumer Healthcare for an undisclosed sum.
21 June 2021
Nearly one in four Europeans, 24%, trust pharmaceutical companies on health issues, according to the Stada Health Report 2021.
21 June 2021
Mark Keatley – former chief financial officer of Stada – has joined the boards of Sweden’s Karo Pharma, Germany’s Neuraxpharm and Sweden’s Recipharm.
18 June 2021
The COVID-19 pandemic has had a significant impact on the mental wellbeing of Europeans, according to the Stada Health Report 2021, which found that almost one in three people, 29%, had suffered from increased levels of anxiety.
18 June 2021
Almost one in three Europeans, 29%, are taking vitamins, minerals and supplements (VMS) more often than usual during the COVID-19 pandemic, according to the Stada Health Report 2021, with women more likely than men to step up their intake of VMS products.
15 June 2021
Stada’s head of Europe, Steffen Wagner, has taken responsibility for the company’s acitivities in Germany following the departure of Eelco Ockers.
24 May 2021
Stada’s Salvatore Butti has been elected president of Assosalute, the Italian self-medication industry association, for a three-year term.